An increasing number of patients are being treated with growth hormone (GH) for the enhancement of body growth but also as an anti-aging strategy. However, the side effects of GH have been poorly defined. In this study we determined the effect of GH on wound repair and its mechanisms of action at the wound site. For this purpose, we performed wound healing studies in transgenic mice overexpressing GH. Full thickness incisional and excisional wounds of transgenic animals developed extensive, highly vascularized granulation tissue. However, wound bursting strength was not increased. Wound closure was strongly delayed as a result of enhanced granulation tissue formation and impaired wound contraction. The latter effect is most likely due to a significantly reduced number of myofibroblasts at the wound site. By using in vitro studies with stressed collagen lattices, we identified GH as an inhibitor of transforming growth factor ␤-induced myofibroblast differentiation, resulting in a reduction in fibroblast contractile activity. These results revealed novel roles of GH in angiogenesis and myofibroblast differentiation, which are most likely not mediated via insulin-like growth factors at the wound site. Furthermore, our data suggested that systemic GH treatment is detrimental for wound healing in healthy individuals.
An increasing number of patients are being treated with growth hormone (GH) for the enhancement of body growth but also as an anti-aging strategy. However, the side effects of GH have been poorly defined. In this study we determined the effect of GH on wound repair and its mechanisms of action at the wound site. For this purpose, we performed wound healing studies in transgenic mice overexpressing GH. Full thickness incisional and excisional wounds of transgenic animals developed extensive, highly vascularized granulation tissue. However, wound bursting strength was not increased. Wound closure was strongly delayed as a result of enhanced granulation tissue formation and impaired wound contraction. The latter effect is most likely due to a significantly reduced number of myofibroblasts at the wound site. By using in vitro studies with stressed collagen lattices, we identified GH as an inhibitor of transforming growth factor ␤-induced myofibroblast differentiation, resulting in a reduction in fibroblast contractile activity. These results revealed novel roles of GH in angiogenesis and myofibroblast differentiation, which are most likely not mediated via insulin-like growth factors at the wound site. Furthermore, our data suggested that systemic GH treatment is detrimental for wound healing in healthy individuals.
Injury to the skin initiates a series of events, which finally lead to at least partial reconstruction of the wounded tissue (1) . The important role of locally acting cytokines and growth factors in wound repair is well documented (2) . However, crucial functions of endocrine-acting hormones have only recently been recognized (3) (4) (5) . One of the hormones, which are thought to influence the repair process, is growth hormone (GH). 1 This hormone is successfully used for the treatment of growth defects in children. In addition, an increasing number of healthy adult patients receive GH therapy as an anti-aging strategy (6) . However, the side effects of GH treatment have been poorly defined, and it is as yet unclear if GH affects the wound healing process in healthy individuals.
Treatment with recombinant GH has been used in patients with severe burn injuries, and in most studies enhanced rates of wound healing and patient survival were observed (7) . In addition, GH was shown to stimulate granulation tissue formation and biomechanical wound strength in animal models of impaired healing (8 -11) , although a lack of efficacy of GH has also been reported (12, 13) . Thus, the role of GH in wound repair remains to be determined. In particular, the mechanisms of GH action in this process have not yet been elucidated.
Many effects of GH are mediated via the insulin-like growth factor (IGF) system (14) , suggesting that this might also be a mechanism of GH action in the skin. IGF-I is a mitogen for keratinocytes (15) , and it stimulates collagen, glycosaminoglycan, and proteoglycan synthesis by dermal fibroblasts (16, 17) . It exerts its effects in concert with a family of six IGF-binding proteins (IGFBPs) that control the availability of IGF for signaling through its receptor in a complex manner. Whereas IGFBP-3 and IGFBP-4 have a predominantly negative effect on IGF activity, IGFBP-5 can act to enhance IGF signaling but only when associated with the surface extracellular matrix of target cells (16, 18) . In addition, IGFBPs also have IGF-independent effects on cell growth (19) .
Most interesting, imbalances in the IGF/IGFBP system are associated with wound healing abnormalities. Thus, up-regulation of IGF or IGFBPs was detected in hypertrophic scars, whereas decreased IGF levels were found in diabetic skin and foot ulcers and in the wounds of healing-impaired diabetic or glucocorticoid-treated rats or mice (2) . Based on these findings, the effect of members of the IGF system on dermal tissue repair has been analyzed. Local IGF gene therapy or protein treatment improved the wound healing process in different animal models (20 -23) . In contrast, raising the serum levels of IGF-I by systemic application did not improve wound healing, although GH was effective in the same experimental set-up, possibly via induction of IGF-I at the wound site (24) .
These findings, together with the obvious importance of the GH/IGF system in the homeostasis of the skin, prompted us to analyze the wound healing process in transgenic mice overexpressing bovine GH (bGH) under a phosphoenolpyruvate car-boxykinase promoter. These mice have greatly elevated postnatal serum GH levels of ϳ2000 ng/ml (compared with less than 10 ng/ml endogenous hormone in control mice) and serum IGF-I levels that are 2-3 times higher than those of control littermates. In contrast to growth hormone treatment models, these animals allow long term studies without immunologic complications (25) . Most interesting, the skin of these animals has a significantly increased absolute (males and females) and relative weight (males only) (26, 27) . GH transgenic males develop a phenotype, which has been likened to an "oversized coat." Although skin alterations in females are moderate, males develop a pronounced dermal hypertrophy with dermal fibrosis and decreased subcutaneous adipose tissue. This malespecific phenotype is dependent on androgen production (26). Here we show that both transgenic males and females suffer from severe wound healing abnormalities.
EXPERIMENTAL PROCEDURES
Animals, Wounding and Preparation of Wound Tissue-Hemizygous phosphoenolpyruvate carboxykinase-bGH transgenic mice in an NMRI outbred background were bred with C57BL/6 wild-type mice. Transgenic and nontransgenic littermates were anesthetized by intraperitoneal injection of ketamine (10 g/liter)/xylazine (8 g/liter) solution (250 l/25 g body weight). Four full thickness excisional wounds, 5 mm diameter each, were made on either side of the dorsal midline by excising skin and panniculus carnosus. Wounds were left uncovered and harvested 5 or 13 days after injury. Mice were housed individually during the healing period. For expression analyses, two complete wounds from each animal including 2 mm of the epithelial margins were excised and immediately frozen in liquid nitrogen. Nonwounded back skin served as a control. For histological analysis the complete wounds were isolated, bisected, fixed overnight in 4% paraformaldehyde in phosphate-buffered saline (for histology) or 95% ethanol, 1% acetic acid (for immunofluorescence, bromodeoxyuridine (BrdUrd) staining, and morphometry), and embedded in paraffin. Sections (7 m) from the middle of the wound were stained using the Masson trichrome procedure. Morphometric measurements of area and length were performed on BrdUrd-stained sections using the OpenLab software (Improvision Ltd., Basel, Switzerland) and are represented as single data points and median (see Figs. 2 , B and C, and 4, I and J). Alternatively, all values ranging from 25% below and above the median were represented as boxes (25th to 75th percentile). In this case the highest and lowest values were also indicated as bars (see Figs. 2D and 4E). Statistical significance of differences was determined by the Mann-Whitney U test for non-Gaussian distribution. All experiments with animals were carried out with permission from the local veterinary authorities.
Wound Bursting Strength-Mice were anesthetized as described above. The dorsal region was shaved and treated with a depilatory agent (Pilca Perfect, Stafford-Miller Continental, Oevel, Belgium). Two full thickness incisions (1 cm) were made, one anterior and one posterior, dorsal site, and the skin margins were closed with strips of a wound plaster (Fixomull stretch, Beiersdorf, Hamburg, Germany). Mice were sacrificed on day 5 post-wounding, and bursting strength of the wounds was determined in situ using the BTC-2000 system (SRLI Technologies, Nashville, TN) according to the manufacturer's protocol for the non-human disruptive linear incision analysis. Data are shown as median, 25th to 75th percentile, and highest and lowest value. Statistical significance of differences in tensile strength between the groups was determined by the Mann-Whitney U test.
Labeling with BrdUrd-BrdUrd labeling was performed as described (28) . Sections (7 m) from the middle of the wound were incubated with a peroxidase-conjugated monoclonal antibody directed against BrdUrd (Roche Diagnostics) and stained with 0.05% diaminobenzidine, 0.01% H 2 O 2 .
Immunofluorescence and Immunohistochemistry-Acetic acid/ethanol-fixed paraffin sections (7 m) from the middle of the wound or immortalized mouse embryonic fibroblasts were incubated with antibodies directed against ␣-smooth muscle actin (SMA) (anti-␣SM-1, IgG2a monoclonal antibody (28)), ED-A fibronectin (IST-9, IgG1 monoclonal antibody, kind gift from Dr. L. Zardi, National Institute for Cancer Research, Laboratory of Cell Biology, Genova, Italy (29)), desmin (D33, IgG1 monoclonal antibody, Dako, Copenhagen, Denmark), PECAM-1 (BD Biosciences), Ly-6G (BD Biosciences), F4/80 (Serotec, Oxford, UK), cytokeratins 6, 14 (Babco, Richmond, CA), and 10 (Dako), followed by Cy2-, Cy3-, Cy5-, FITC-or TRITC-, Alexa647-, or Alexa568-conjugated conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA, and Molecular Probes, Eugene, OR). Cell nuclei were stained with DAPI (Sigma) and F-actin with phalloidinAlexa488 (Molecular Probes). Subsequently, slides were washed in phosphate-buffered saline, prior to mounting in Tris/glycerol containing n-propyl gallate, and analyzed using a Leica DM IRBE fluorescence microscope equipped with a TCSNT confocal laser system or a Leica DM RXA2 upright microscope, equipped with a laser-scanning confocal head (TCS SP2 AOBS). Conventional immunofluorescence images were analyzed on a Zeiss Axiovert 100 microscope.
Quantification of ␣-SMA Expression by Fluorescence Image Analysis-Expression levels of ␣-SMA in sections of wound granulation tissue were quantified as described (30) . Briefly, sections were triple-immunostained for ␣-SMA, desmin, and cell nuclei, and confocal digital images were taken using a Plan-Neofluar ϫ40/1.3 objective (Zeiss) mounted on a Zeiss Axiovert 200M, equipped with a spinning disk Nipkow confocal head (Yokogawa CSU10, Visitron Systems, Puchheim, Germany), CoolSNAP-HQ monochrome digital CCD camera (Photometrics, Roper Scientific, Inc., Trenton, NJ), and image acquisition software (MetaMorph, Universal Imaging Corp. Downington, PA). For each image a region of interest was manually selected, including the granulation tissue, and all further automatic processing was restricted to this region. First, desmin staining, specific for vascular smooth muscle cells, was subtracted from ␣-SMA and DAPI images in order to exclude vessels from ␣-SMA quantification. Second, ␣-SMA expression was analyzed by calculating the mean pixel intensity of the whole region of interest after background correction and related to the number of cell nuclei obtained from the desmin-corrected DAPI image. Tissue was collected from three animals per experimental condition; three sections were prepared per animal, and four regions of interest were analyzed per section.
Immunohistochemistry and Quantification of Blood Vessels-For immunohistochemistry, sections were deparaffinized and treated for 40 min at room temperature with 1.5% H 2 O 2 in methanol to block endogenous peroxidases. After a 30-min incubation with 10% rabbit serum, sections were incubated overnight at 4°C with the PECAM-1 antibody, followed by a 1-h incubation with biotinylated donkey anti-rat IgG (Dianova, Hamburg, Germany). Detection was performed with the peroxidase substrate kit (Vector Laboratories), as described by the manufacturer. Sections were counterstained with hematoxylin, mounted, and analyzed using a Zeiss Axioskop 2 equipped with a Zeiss AxioCam HRc camera. Stained vessels within an area of 0.2 ϫ 0.5 mm below the hyperproliferative epithelium were counted.
Relaxed and Stressed Collagen Lattice Contraction-To determine the effect of GH on the contractile activity of immortalized embryonic murine fibroblasts, cells were grown in stressed collagen lattices (31) at 1.75 ϫ 10 5 cells/ml for 5 days (with our without 1 ng/ml TGF-␤1). Attached lattices were then released, and diameter reduction after 30 min was normalized to the initial gel diameter. In one experimental series, mouse sera and GH were added from the beginning of the 5-day (long term) culture and in a second series only 5 h (short term) prior to gel release. Tractional cell forces were assessed using relaxed, freefloating collagen lattices as described (32). 9 ϫ 10 4 cells/ml gel were seeded into 6-cm Petri dishes, and collagen gel areas were measured 12 h later. A minimum of 3 lattices was assayed, and experiments were performed in duplicates.
Acetic Acid Extraction of Proteins from Skin-Skin samples were homogenized in liquid nitrogen and extracted in 1 M acetic acid for 2 h at 4°C. Samples were then centrifuged for 5 min at 11,000 ϫ g at 4°C, and the supernatant was frozen. Pellets were re-extracted in 1 M acetic acid as described above. Supernatants were combined and stored at Ϫ20°C overnight. Before determination of protein concentration, the samples were again centrifuged, and the supernatants were transferred to fresh tubes, whereas the newly formed precipitate was discarded.
Western Blot Analysis-15 g of total protein from lysates of 5-day wounds of wild-type and transgenic mice were separated by SDS-PAGE and transferred to nitrocellulose membranes. Membranes were probed with primary antibodies against ␣-SMA and ED-A fibronectin, stripped, and re-probed for total actin using antibody rabbit antibody (Sigma). Detection was performed with secondary antibodies conjugated to horseradish peroxidase (Jackson ImmunoResearch) and the ECL chemiluminescence detection system (Amersham Biosciences). Bands were digitized with a scanner, and the ratio between all band densities of one blot was calculated by commercial computer software (ImageQuant version 3.3, Amersham Biosciences). Relative protein expression was normalized to the respective values for total actin. Samples from four animals per experimental condition were used to calculate mean protein/total actin ratio.
Western Ligand Blotting-Ligand blot analysis of IGFBPs present in the skin was performed according to Ref. 33 , with modifications (34). Briefly, protein samples were diluted 1:2 with sample buffer (62.5 mM Tris-HCl (pH 6.8), 2% (w/v) SDS, 10% (w/v) sucrose), boiled (5 min), and electrophoresed on a 5% stacking/12% separating SDS-polyacrylamide gel. Separated proteins were transferred to polyvinylidene difluoride membrane (Millipore, Eschborn, Germany). Blots were blocked with 1% fish gelatin and incubated with 125 I-IGF-II (10 6 cpm per blot). Binding proteins were visualized and quantified by using the PhosphorImager and the ImageQuant software (Amersham Biosciences).
Radioimmunoassays for IGF-I, IGF-II, and IGFBP-2-IGF-I
, IGF-II, and IGFBP-2 were measured using radioimmunoassays described before (35, 36) . For all assays, dilution curves of mouse samples were linear and paralleled those of human standards.
RESULTS

bGH Transgenic Mice Show Excessive Granulation Tissue
Formation and Reduced Wound Closure at Day 5 after Wounding-We generated full thickness excisional wounds in bGH transgenic mice and control littermates, and we sampled the excised wounds for histological analysis at day 5 after injury (14 wounds from 7 transgenic males, 12 wounds from 6 wildtype males, 13 wounds from 7 transgenic females, and 14 wounds from 7 wild-type females). At this time point, the inflammatory response is still strong on the one hand, and on the other hand re-epithelialization is already well underway. Furthermore, part of the clot has been replaced by granulation tissue, which consists of inflammatory cells, endothelial cells, and fibroblasts, which deposit large amounts of new extracellular matrix (1, 2). Fig. 1 shows representative Masson trichrome-stained sections of wounds from transgenic males and females in comparison to their wild-type littermates. Wounds were much wider in the transgenic animals of both sexes and filled with a large and cell-rich granulation tissue ( Fig. 1, A, C , E, and G, arrowheads). A large fraction of the wound was not yet covered by epidermis ( Fig. 1, A, C , E, and G, arrows). In the wild-type animals, on the other hand, the granulation tissue was much less extended, and therefore, a significant part of the wound was already covered by newly formed epidermis ( Fig. 1 , B, D, F, and H, arrows). Finally, the outer margins of the hyperproliferative epithelium (HE) had moved toward each other due to contraction of the wounds (Fig. 1 
, B, D, F, and H, arrowheads).
In addition to the size, the quality of the granulation tissue was also very different between transgenic mice and control animals. Cells had invaded into most parts of the original clot, and a significant amount of matrix had been deposited in bGH-overexpressing mice (see blue collagen staining). By contrast, the loose, spongy tissue characteristic for the blood clot was only partially replaced by granulation tissue in control mice (Fig. 1, B, D, and F) . In a few wild-type mice, where most of the clot was replaced by granulation tissue at day 5 after injury ( Fig. 1H) , the granulation tissue was much less extended compared with transgenic mice.
The oval structures that are detectable in the granulation tissue of some transgenic animals were identified as hypertrophic nerve fibers after staining of the sections with an antibody against neurofilament M (data not shown). They were also detected in most control wounds and to a lesser extent in wild-type mice of other mouse strains (data not shown). Therefore, they appear not to be the result of bGH overexpression. To quantify the histological data, one set of sections from one wounding experiment (including 5 wounds from 3 transgenic males, 4 wounds from 2 wild-type males, 4 wounds from 2 transgenic females, and 5 wounds from 3 wild-type females) was used to measure the cross-sectional area of the granulation tissue ( Fig. 2A, encircled area) and the progress of wound closure (% of distance covered by epidermis between the wound edges that are indicated by arrowheads in Fig. 1, A-H, and Fig.  2A ). Differences in wound closure (p ϭ 0.0159) and granulation tissue area (p ϭ 0.0317) were significant in both sexes (Fig. 2,  B and C) .
To determine the rate of cell proliferation within the hyperproliferative epithelium, the animals were injected with BrdUrd 2 h prior to sacrifice, and sections from the center of the wounds were stained with an antibody directed against BrdUrd. The percentage of stained, proliferating cells was similar in wild-type and transgenic animals (data not shown). Consistent with this finding, the area of the HE, as well as its length along the border between epidermis and dermis, which reflects the rate of keratinocyte migration, was not significantly different between bGH transgenic and wild-type mice (data not shown). These results demonstrate that the reduced wound closure is not the result of delayed re-epithelialization but rather of enhanced granulation tissue formation and reduced wound contraction.
Excessive Formation of Granulation Tissue Does Not Lead to a Higher Wound Bursting Strength in bGH Transgenic
Mice-To determine whether the formation of a larger and denser granulation tissue in the bGH transgenic animals leads to a functional improvement, we generated incisional wounds on the back of bGH transgenic and wild-type males and females. Because incisional wounds are fully healed at day 5 after injury, we sacrificed the animals at this time point and measured the negative pressure at which the wounds ruptured. No significant improvement of bursting strength in transgenic versus wild-type animals was found; rather, the median bursting strength was slightly higher in both wild-type males and females, compared with bGH transgenic males and females, respectively (Fig. 2D) . Similar to the results from excisional wounds, histology of incisional wounds showed an increase, albeit smaller, in the density and volume of the granulation tissue (data not shown). Thus, the excessively dense and thick granulation tissue in bGH transgenic animals does not function to confer a higher bursting strength.
Altered Neovascularization in 5-Day Wounds of bGH Transgenic Animals-Analysis of Masson trichrome-stained sections
suggested that the number of blood vessels is enhanced in bGH transgenic animals. To verify this impression, we performed immunofluorescence staining on paraffin sections of 5-day wounds using an antibody against CD31/PECAM (Fig. 3, green) combined with confocal laser-scanning microscopy. This staining revealed an increase in the number and size of newly formed blood vessels (Fig. 3, A and C) , compared with wounds of wild-type mice (Fig. 3, B and D) . Similar alterations were observed in transgenic versus wild-type males. To quantify the difference, we counted the number of blood vessels below the hyperproliferative wound epidermis in immunohistochemically stained sections. The difference was statistically significant (p ϭ 0.0373) in female but not in male transgenic mice (p ϭ 0.0703) (Fig. 3E) . By contrast, we observed a decreased number of blood vessels within the uninjured skin of transgenic males (data not shown), demonstrating that bGH alone does not enhance dermal vascularization but rather requires the presence of additional factors at the wound site to enhance this process.
In contrast to angiogenesis, no obvious difference in the number of macrophages was detected between transgenic and wild-type mice as determined by staining the wound sections with an antibody against the F4/80 antigen (data not shown). Staining of the keratinocyte-specific markers cytokeratin 14 (Fig. 3, A-D, red), cytokeratin 10 (Fig. 3, A and B, blue-purple) , (Fig. 1) was subjected to morphometric analysis as illustrated in A. The area of granulation tissue, which was measured, is encircled by a black line. Wound closure was determined as percentage of distance covered by epidermis between the wound edges that are indicated by arrowheads in Fig. 1, A-H, and 2A) . A-D, paraffin sections prepared from 5-day wounds of bGH transgenic mice or their wild-type siblings were triple-stained with a polyclonal antiserum against cytokeratin 14, followed by Cy-3-conjugated anti-rabbit IgG (red); a rat monoclonal antibody against CD 31/PECAM, followed by FITC-conjugated anti-rat-IgG (green); and a mouse monoclonal antibody against cytokeratin 10, followed by Cy-5-conjugated anti-mouse IgG (blue; signal throughout the fibrin clot/granulation tissue probably represents binding to mouse serum IgGs). Shown are low magnification views of representative wound edges (A and B, bars represent 100 m) and higher magnification views of areas of the fibrin clot/granulation tissue underlying the hyperproliferative epithelium (C and D, bars represent 20 m). D, dermis; E, epidermis; G, granulation tissue; HE, hyperproliferative epithelium. E, quantification of blood vessels below the hyperproliferative epithelium in sections from female transgenic (tg) mice (10 wound halves) and control animals (5 wound halves) and from male transgenic mice (8 wound halves) and control animals (5 wound halves) revealed a significantly higher number of vessels in transgenic females compared with controls (p ϭ 0.0373), whereas the difference was not significant in males (p ϭ 0.0703). wt, wild type. Shown are median values, 25th to 75th percentile (boxes) and range (vertical bars). analyzed). At this time point, re-epithelialization was completed in wild-type animals, leaving behind a hyperproliferative epithelium and a granulation tissue, and both had been greatly reduced in size during the 2nd week after injury. By contrast, bGH transgenic males (Fig. 4 , A and C) still had an extensive hyperthickened epithelium, and most notably, 2 of the 10 wounds analyzed were not yet completely re-epithelialized. In wild-type males, on the other hand, contraction of the wounds had brought the margins of the HE closely toward each other (arrowheads in Fig. 4, B and D) . Furthermore, in transgenic males a granulation tissue several times the size of that in wild-type animals in height and width was revealed. All transgenic females had re-epithelialized their wounds after 13 days. Very few wounds taken from transgenic females still had an enlarged wound epithelium and granulation tissue (Fig.   4E) ; in the majority of these wounds (Fig. 4G) , the sizes of these compartments were similar to those found in wild-type females (Fig. 4, F and H) .
The cross-sectional areas of HE and granulation tissue measured in 13-day wounds are summarized in Fig. 4, I and J, respectively. For each gender, three independent wounding experiments were performed, from which data were compiled and sections through the middle of the wounds were selected (9 wounds from 5 transgenic males, 8 wounds from 5 wild-type males, 5 wounds from 3 transgenic females, and 7 wounds from 5 wild-type females). The areas were significantly different (HE; p ϭ 0.0003, granulation tissue; p ϭ 0.0025) between transgenic and wild-type males but not between transgenic and wild-type females. In accordance with these observations, the percentage of BrdUrd-positive proliferating cells, as well as total cell number within the wound epidermis were still significantly higher in the transgenic males in comparison to wildtype males (% BrdUrd positive cells, p ϭ 0.0091; total number of cells, p ϭ 0.0001), whereas these parameters were not significantly different between transgenic and wild-type females. The increased area and length of the wound epidermis in male animals is most likely due to the extended granulation tissue that had to be covered, leading to prolonged keratinocyte hyperproliferation. Consistent with this finding, we found a prolonged expression of the differentiation-specific keratin 6 in transgenic males (data not shown). Together, these data indicate that wound closure is delayed in male and female bGH transgenic mice within the first 5 days after injury and even longer in the male animals.
Altered Myofibroblast Differentiation and Organization of ␣-SMA in 5-Day Wounds of bGH Transgenic
Animals-Of particular importance for wound contraction and closure is a subpopulation of fibroblasts that differentiate into myofibroblasts during the course of wound healing (37) . To investigate whether the obvious defect in wound contraction in the bGH transgenic animals is due to alterations in myofibroblast differentiation, sections were stained for ␣-SMA, which is expressed by myofibroblasts. In wounds from wild-type females, a highly organized structure of ␣-SMA-containing stress fibers underlying the hyperproliferative epithelium was revealed (Fig. 5, B and D, green) , with filaments extending along the hyperproliferative wound epithelium and also underneath the uninjured dermal tissue at the edge of the wound toward the subcutaneous muscle, the panniculus carnosus. The latter can be identified on the basis of strong desmin staining (Fig. 5, B  and D, red) . In the granulation tissue, ␣-SMA-expressing cells could unmistakably be identified as myofibroblasts (Fig. 5, B and D, green), because they were negative for desmin in contrast to smooth muscle cells of small vessels, which co-express ␣-SMA and desmin (Fig. 5, C and D, yellow, indicated by  arrows) . However, in wounds from transgenic females, fewer myofibroblasts residing underneath the keratinocyte tongues at the wound edges expressed much less ␣-SMA, most of which was not organized into parallel filaments but rather extended in all directions (Fig. 5, A and C, green) . A similar difference was also seen in male mice (data not shown). Quantification of myofibroblast appearance in granulation tissue by immunofluorescence intensity analysis of 5-day wound sections demonstrated ϳ3 times higher ␣-SMA expression in female wild-type compared with transgenic mice. This was confirmed by Western blot analysis of total lysates of 5-day wound tissue (Fig. 6,  A and B) , revealing a 3-and 2.5-fold higher expression of ␣-SMA in wild-type male and female mice compared with their respective transgenic littermates. A second marker for myofibroblasts, ED-A fibronectin (38) , was expressed at significantly higher levels in wild-type (4-fold) compared with transgenic female mice but exhibited similar expression levels in male transgenic and control mice. These results suggest that impaired wound contraction in bGH transgenic animals correlates with a decreased number of myofibroblasts and an impairment of stress fiber organization in wound myofibroblasts.
Effect of bGH on Collagen Contraction and Myofibroblast Differentiation-As a next step we determined whether the impaired wound contraction, which we observed in bGH-overexpressing transgenic mice, is a direct effect of GH on the generation of contractile and tractional forces by fibroblasts. For this purpose we analyzed the effect of recombinant bGH on the ability of murine embryonic fibroblasts to contract attached (stressed) three-dimensional collagen lattices, which are a model of the organized matrix in advanced granulation tissue (37) , and to retract freely floating (relaxed) gels, in which loose collagen fibrils are reorganized by migrating fibroblasts (39), comparable with early dermal wound healing. The GH concentrations that we used ranged from 0.1 to 10% of the serum concentrations of bGH transgenic mice, and therefore likely reflect the concentrations that reach the fibroblasts within the dense granulation tissue. When GH was added for 5 h to attached (Fig. 7A, control) and 12 h to free-floating gels (data not shown) in control medium, we did not observe any inhibitory effect of GH on collagen area reduction, but rather a tendency of this hormone to enhance contraction/retraction in a dose-dependent manner. As a next step, we determined whether growth hormone affects myofibroblast differentiation and the contractile ability of these cells. For this purpose, fibroblasts were cultured for 5 days in the presence of transforming growth factor ␤1 (TGF-␤1). This factor was chosen, because TGF-␤s are the most potent known inducers of myofibroblast differentiation (31, 40) , and because TGF-␤1 is the predominant TGF-␤ isoform in murine skin wounds (41) . When fibroblasts were grown for 5 days in stressed gels in the presence of TGF-␤1, i.e. when myofibroblast differentiation has been induced, short term addition of GH moderately decreased myofibroblast contractile activity (Fig. 7A, TGF-␤1 ). Most interesting, addition of GH for the whole culture period of 5 days had no effect on stressed collagen contraction in control medium (Fig. 7C, control) , but significantly reduced the contractile activity of (myo)fibroblasts grown in the presence of TGF-␤1 (Fig. 7C, TGF-␤1 ).
Next, we tested the possibility that the serum of bGH transgenic mice contains an inhibitory activity, which counteracts the positive short term influence of GH on fibroblast collagen gel reduction. In control medium, replacement of 5% FCS with pooled sera of transgenic or wild-type mice resulted in an improvement of gel retraction (data not shown) and contraction when added for 5 h (Fig. 7B, control) and 5 days (Fig. 7D,  control) ; this effect is presumably due to the greater efficiency of murine over bovine growth factors. At lower concentrations of mouse sera, the degree of collagen gel retraction was intermediate between the control and the 5% mouse serum values, but no significant difference was seen between sera from transgenic or wild-type mice at any concentration tested (data not shown). When added to TGF-␤1-treated (myo)fibroblasts, serum from transgenic mice slightly reduced stressed collagen contraction compared with 10% FCS and wild-type mouse serum (Fig. 7, B and D, TGF-␤1) .
To assess the level of myofibroblast differentiation, murine FIG. 5 . Altered myofibroblast differentiation in bGH transgenic mice. Paraffin sections prepared from 5-day wounds of bGH transgenic (tg) mice or their wild-type (wt) siblings were triplestained with a polyclonal antiserum against cytokeratin 14 followed by Alexa647-conjugated anti-rabbit IgG (A-D, blue), a mouse monoclonal IgG2a antibody against ␣-SMA (green), followed by FITC-conjugated anti-mouse IgG2a and a mouse monoclonal IgG1 antibody against desmin (red) followed by TRITC-conjugated anti-mouse IgG1. Sections were viewed by laser confocal microscopy, and overlays were prepared from the extended view images from all three channels. embryonic fibroblasts were treated for 5 days with TGF-␤1 in the presence or absence of bGH or mouse sera. TGF-␤1 strongly induced expression of ␣-SMA (Fig. 7E) , compared with almost ␣-SMA-negative cells grown in control medium (data not shown). This ␣-SMA-inducing effect of TGF-␤1 was completely abolished by simultaneously adding GH (Fig. 7F ) and moderately reduced by transgenic mouse serum (Fig. 7H) ; wild-type mouse serum did not change ␣-SMA expression of TGF-␤1-treated fibroblasts (Fig. 7G) . When added to fibroblasts in control medium, GH and mouse sera had no significant effect on ␣-SMA expression (data not shown).
Thus in long term experiments, GH appears to inhibit TGF-␤1-induced myofibroblast differentiation and ␣-SMA expression, which is most likely responsible for reduced collagen (31) and wound contraction. Moreover, in short term treatment, GH seems to inhibit the contractile activity of differentiated myofibroblasts but not the retraction forces exerted by ␣-SMAnegative fibroblasts.
Elevated Levels of IGFBPs, but Not of IGF-I, in 5-Day Wounds of bGH Transgenic
Mice-Because many effects of GH are mediated via IGFs, we compared the levels of IGFs and IGF binding activities in skin and wound lysates derived from bGH transgenic mice and wild-type mice. IGF-I levels in protein lysates prepared from individual mice (n ϭ 4) were determined by quantitative radioimmunoassay (Fig. 8A) . As reported previously for serum IGF-I levels (27), they were elevated by a factor of 2-3 in transgenic skin of both males and females, compared with wild type (males, p ϭ 0.0006; females, p ϭ 0.0008). In the females, a 6-fold up-regulation of IGF-I protein in comparison to nonwounded skin was observed in both wildtype and transgenic animals at day 5 after injury; however, no difference was observed between transgenic and wild-type animals. Much less up-regulation of IGF-I was observed in the males; levels in 5-day wounds of both wild-type and transgenic males were similar to those in the uninjured skin of transgenic males. The difference between males and females was highly significant for both wild-type (p ϭ 0.0037) and transgenic mice (p ϭ 0.0025). Thus, first, IGF-I levels seem to be generally lower in healing wounds of male mice, compared with females; and second, in bGH transgenic mice of both genders, the higher abundance of IGF-I in intact skin of transgenic mice compared with wild-type mice is not maintained after injury. When levels of IGF-II and IGFBP-2 within the same samples were determined, no significant differences were revealed between wildtype and bGH transgenic mice (data not shown).
IGF binding activities in skin and 5-day wounds were analyzed by Western ligand blotting of protein lysates from individual mice (n ϭ 3 for each gender and genotype) with a radiolabeled IGF-II tracer (Fig. 8B) . Three labeled bands visualized on the blots corresponded to IGFBP-3 (35-45 kDa), IGFBP-5 (25-35 kDa), and IGFBP-4 (18 -25 kDa), the three IGF-binding proteins, which are expressed mainly by dermal fibroblasts (18, 42) . An increase in IGF binding to all three proteins could be observed in skin lysates from both transgenic males and females, compared with wild-type animals; this increase was significant for IGFBP-3 in both genders (males, p ϭ 0.0085; females, p ϭ 0.0013) and for IGFBP-4 in the females (p ϭ 0.017), and not significant in the other skin samples, due to larger variations between the individuals. Following injury, IGF binding activity was up-regulated (2-4-fold in the wildtype animals and 1.5-3-fold in bGH transgenic mice). In 5-day wound lysates, a significant difference was observed between wild-type and bGH transgenic mice in binding to both IGFBP-3 (males, p ϭ 0.0052; females, p ϭ 0.025) and IGFBP-4 (males, p ϭ 0.0014; females, p ϭ 0.0008), whereas no difference was apparent in binding to IGFBP-5. Thus, overall in the wounds of bGH transgenic mice the balance between IGFs and IGFBPs is shifted toward an under-abundance of IGF-I and a greater relative activity of the predominantly inhibitory IGF-binding proteins IGFBP-3 and IGFBP-4.
DISCUSSION
Growth Hormone, Beneficial or Detrimental for Wound Healing?-We have studied the wound healing process in transgenic mice with highly elevated levels of serum bGH. The most striking phenotype was the strong increase in granulation tissue formation in female and male transgenic animals. This result is consistent with data obtained by other investigators who found that local or systemic application of GH stimulates granulation tissue formation in wounds of normal and malnourished rats (8, 43) . However, in the latter and in other studies (9) , the increased granulation tissue correlated with an improved biomechanical strength of the wounds. By contrast, we could not detect an increase in wound bursting strength, demonstrating that matrix maturation is not improved by the elevated levels of bGH. These discrepancies between our results and previous studies might result from the use of healingimpaired animals in most treatment studies. These animals suffer from reduced mechanical wound strength, which is likely to be improved by application of GH. However, we show that GH is not able to increase further the normal bursting strength of a noncompromised wound and can even delay the wound healing process. Thus, GH treatment of healthy individuals appears to have adverse effects on skin wound healing. On the other hand, GH was found to be helpful in severely burned animals or patients, who are characterized by the induction of a catabolic state with decreased GH and IGF levels. In this case the action of exogenously administered GH may lie more in the restoration of the anabolic metabolism, rather than in the stimulation of tissue repair at the cellular level (7) .
Enhanced Wound Angiogenesis in bGH Transgenic Mice-A remarkable feature of the granulation tissue of bGH transgenic mice was the increased number of blood vessels. This may be a direct effect of GH, because the latter was shown to stimulate angiogenesis (44, 45) . However, GH alone is not sufficient to stimulate this process in the skin, because the number of blood vessels in unwounded skin of bGH transgenic males was even reduced. Thus, additional factors present at the wound site are likely to contribute to the increased angiogenesis. Possible candidates are vascular endothelial growth factor, IGF-I, and TGF-␤1, angiogenic factors that are overexpressed in skin wounds (2) . These growth factors might act synergistically with GH to stimulate angiogenesis. By contrast, they are probably not directly responsible for the increase in vessel number and size, because their expression was not enhanced in wounds of bGH transgenic mice compared with control animals (data not shown). Furthermore, IGF-I activity in wounded skin of bGH mice appears even reduced due to the enhanced expression of inhibitory IGFBPs at the wound site. Therefore, the stimulatory effect of GH on granulation tissue formation is most likely not mediated via IGF-I.
Abnormal Wound Contraction and Myofibroblast Differentiation in bGH Transgenic Mice-The most striking abnormality FIG. 7 . Effects of bGH and transgenic mouse serum on stressed collagen gel contraction and myofibroblast differentiation. Immortalized mouse fibroblasts were seeded into mechanically stressed, attached collagen gels and grown for 5 days (5d) in normal medium (control) and medium containing 1 ng/ml TGF-␤1 (TGF-␤1) in order to induce myofibroblast differentiation. Gels were additionally treated with different concentrations of bGH (12.3, 61.3, or 245 ng/ml) (A and C) or 5% FCS ϩ 5% pooled sera from wild-type mice or from their bGH transgenic siblings (bGH levels in pooled sera from transgenic mice were 1.6 g/ml) (B and D). Treatment was either short termed (5h, A and B) or performed during the whole culture period of 5 days (C and D). After 5 days, attached gels were released, and area reduction after 30 min was normalized to control contraction (10% FCS). Indicated in column charts: *, p Յ 0.05; **, p Յ 0.01; ***, p Յ 0.001 as tested by means of a two-tailed heteroscedastic Student's t test within one experimental condition (control, TGF-␤1) against the respective 0 value (A and C) or between wt and tg contraction (B and D); n ϭ 3. After 5 days culture in medium containing 1 ng/ml TGF-␤1 (E) and additionally 245 ng/ml bGH (F), 5% serum from wild-type mice ϩ 5% FCS (G), or 5% serum from transgenic mice ϩ 5% FCS (H), cells were stained for ␣-SMA (red), F-actin (phalloidin, green), and nuclei (DAPI, blue) to determine the level of myofibroblast differentiation. Note that bGH significantly reduces the level of ␣-SMA expression. Bar, 50 m.
in the bGH transgenic mice was the inefficient wound contraction, leading to a delay in wound closure, which is more pronounced in the males than in the females. It has been suggested that the initial closure of the wound is due to tractional forces that are developed by migrating fibroblasts (46) . This process can be mimicked in vitro by using free-floating collagen lattices, where the reduction in collagen lattice diameter is entirely due to tractional forces exerted by fibroblasts (39) . However, collagen gel retraction in vitro was even enhanced by recombinant bGH and by serum from bGH transgenic mice. The positive effect may result from the induction of IGF-I expression in fibroblasts by bGH, because IGF-I is known to promote fibroblast-mediated collagen gel contraction (47, 48) .
At later stages of wound healing, a subpopulation of fibroblasts differentiates into myofibroblasts, which are thought to be responsible for contraction of the granulation tissue (37) . Remarkably, a strongly reduced number of myofibroblasts was observed in bGH transgenic mice, and the existing myofibroblasts showed a decrease in the abundance of parallel ␣-SMA containing stress fibers. This finding suggests that the contractile capability of the existing myofibroblasts is impaired. Of particular importance for myofibroblast differentiation is TGF-␤1 (40) . The normal expression of this growth and differentiation factor in bGH transgenic mice suggests that alterations in the levels of TGF-␤1 are not responsible for the defect in myofibroblast differentiation. By contrast, our in vitro studies with stressed three-dimensional collagen lattices revealed that GH reduces the contractile activity of (myo)fibroblasts grown in the presence of TGF-␤1. Consistent with this observation, TGF-␤1-induced myofibroblast differentiation in vitro was strongly inhibited by long term treatment with bGH. This result revealed a novel role of GH as an inhibitor of TGF-␤-induced myofibroblast differentiation and suggests that this hormone also impairs TGF-␤-induced myofibroblast differentiation and the contractile capacity of these cells in wounded skin.
Interaction of Growth Hormone with Androgens at the Wound Site?-Most interesting, the enlarged, highly vascularized granulation tissue and the myofibroblast abnormalities were observed in both male and female transgenic mice. This finding demonstrates that the abnormalities seen in early wounds are not a result of the highly fibrotic skin of male transgenic animals, which could impair wound contraction.
Rather, bGH appears to affect granulation tissue formation in mice of both genders in a similar manner. However, the phenotype was stronger in the male animals, possible due to the influence of sexual hormones as already observed in noninjured skin of these animals (26). In this study, the severe skin fibrosis seen in male animals was prevented when the animals were castrated, demonstrating that androgens synergize with GH and possibly locally acting growth factors to induce skin fibrosis. In analogy, the continuous production of matrix at the wound site and the extension of the inflammatory phase (data not shown) could also be influenced by androgens. This hypothesis is supported by the findings of Ashcroft and Mills (5), who found that testosterone is a negative regulator of wound healing and enhances the inflammatory response by up-regulation of pro-inflammatory cytokines.
In summary, we have shown striking effects of enhanced serum GH levels on the wound healing process. In addition to its known effect on granulation tissue formation, our results revealed a novel role of GH in wound angiogenesis. Most interesting, GH was identified as an inhibitor of TGF-␤-induced myofibroblast differentiation. Finally, our data strongly suggest that systemic GH treatment is detrimental for wound healing in healthy individuals, in particular in males. Levels of IGF-I in total protein lysates prepared from uninjured skin and 5-day wounds (5d W) of bGH transgenic (tg) males and females and their wild-type (wt) littermates were determined by quantitative radioimmunoassay, and means and S.E. were calculated (A). Significant differences were revealed between transgenic and wild-type skin of both males (p ϭ 0.0006) and females (p ϭ 0.0008). Aliquots of total protein lysates from uninjured skin and 5-day wounds of bGH transgenic males and females and their wild-type littermates were subjected to Western ligand blot analysis using radiolabeled IGF-II tracer (B and C). Binding activity was determined separately for three different samples per gender, genotype, and condition in one experiment, and means and S.E. were calculated (B). IGFBP-3 binding was significantly different between transgenic and wild-type animals in the skin of males (p ϭ 0.0085) and females (p ϭ 0.0013), as well as in 5-day wounds of males (p ϭ 0.0052) and females (p ϭ 0.025). IGFBP-4 binding was significantly different between transgenic and wild-type animals in the skin of the females only (p ϭ 0.017) and in 5-day wounds of both males (p ϭ 0.0014) and females (p ϭ 0.0008). *, p Ͻ 0.05; **, p Ͻ 0.01; ***, p Ͻ 0.001. As an example, the image of a ligand blot prepared in a different experiment with 5-day wound samples of females is also shown (C). Right margin, 3-5 indicates the positions of the bands corresponding to IGFBP-3, IGFBP-5, and IG-FBP-4. Note that the medium size band in the serum-positive control (S), which corresponds to IGFBP-2, does not co-migrate with IGFBP-5.
